Cure My Disease

Don't miss your cure!

 Log in / Sign up

New heart valve device tested in early trial

NCT ID NCT07450911

Recruiting now Disease control Sponsor: ReValve Solutions Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 10, 2026 · Updated 4 times

Summary

This early study is testing a new device called the ReValve System to replace the mitral valve in people with severe mitral regurgitation (a leaky heart valve). The trial will enroll 20 people who are eligible for mitral valve surgery. The main goal is to see if the device can be delivered successfully and reduce the leak.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ReValve System (mitral valve replacement device)
What this could lead to
If successful, this could offer a new treatment option for people with severe mitral regurgitation who need valve replacement.
What could go wrong
This is a very early, small trial (20 people) testing safety and technical success. The device may not work as expected or could cause complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

mitral valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MITRAL REGURGITATION

Contacts and locations

Locations

  • Healthycore

    RECRUITING

    Tbilisi, Georgia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tbilisi Heart and Vascular Center

    RECRUITING

    Tbilisi, Georgia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tiblisi Heart Center

    RECRUITING

    Tbilisi, Georgia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.